PubMed Journals Articles About "Late John Mendlein Joins Reinventing Biotech Lineup April" 
Late John Mendlein Joins Reinventing Biotech Lineup April PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Late John Mendlein Joins Reinventing Biotech Lineup April articles that have been published worldwide.
More Information about "Late John Mendlein Joins Reinventing Biotech Lineup April" on BioPortfolio
We have published hundreds of Late John Mendlein Joins Reinventing Biotech Lineup April news stories on BioPortfolio along with dozens of Late John Mendlein Joins Reinventing Biotech Lineup April Clinical Trials and PubMed Articles about Late John Mendlein Joins Reinventing Biotech Lineup April for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Late John Mendlein Joins Reinventing Biotech Lineup April Companies in our database. You can also find out about relevant Late John Mendlein Joins Reinventing Biotech Lineup April Drugs and Medications on this site too.
Showing "Late John Mendlein Joins Reinventing Biotech Lineup April" PubMed Articles 1–25 of 14,000+
Sequential Lineup Laps and Eyewitness Accuracy.
Police practice of double-blind sequential lineups prompts a question about the efficacy of repeated viewings (laps) of the sequential lineup. Two laboratory experiments confirmed the presence of a sequential lap effect: an increase in witness lineup picks from first to second lap, when the culprit was a stranger. The second lap produced more errors than correct identifications. In Experiment 2, lineup diagnosticity was significantly higher for sequential lineup procedures that employed a single versus doub...
Predictors of Eyewitness Identification Decisions from Video Lineups in England: A Field Study.
Eyewitness identification decisions from 1,039 real lineups in England were analysed. Identification procedures have undergone dramatic change in the United Kingdom over recent years. Video lineups are now standard procedure, in which each lineup member is seen sequentially. The whole lineup is seen twice before the witness can make a decision, and the witness can request additional viewings of the lineup. A key aim of this paper was to investigate the association between repeated viewing and eyewitness dec...
Biodefense: 10 years after. Reinventing Project BioShield.
Reinventing image plate workflow.
Reinventing personal glucose devices.
Urban ecosystems research joins mainstream ecology.
Cytokines: IL-17C joins the family firm.
Biotech 101: An Educational Outreach Program in Genetics and Biotechnology.
Recent advances in research and biotechnology are making genetics and genomics increasingly relevant to the lives and health of the general public. For the public to make informed healthcare and public policy decisions relating to genetic information, there is a need for increased genetic literacy. Biotech 101 is a free, short-course for the local community introducing participants to topics in genetics, genomics, and biotechnology, created at the HudsonAlpha Institute for Biotechnology. This study evaluate...
Dementia and Poor Surgical Outcomes: Reinventing the Wheel or Providing Empirical Evidence?
Transcription of promoter from the human APRIL gene regulated by Sp1 and NF-kB.
A proliferation-inducing ligand (APRIL) which stimulates the cell proliferation is abundantly expressed in colorectal cancer (CRC) tumors. In this report, the promoter region of the APRIL gene was determined and the major transcription factor was investigated for the first time. Deletion analysis of 5'-flanking region of the human APRIL gene and transient transfection revealed that a 538 bp region (from -1539 to -1001) was essential for promoter activation of the APRIL gene. The data from electrophoretic...
miR-605 joins p53 network to form a p53:miR-605:Mdm2 positive feedback loop in response to stress.
Telomeres and inflammation: Rap1 joins the ends?
Diluted magnetic semiconductors: Copper joins the family.
Commercialisation of Regenerative Medicine: Learning from Spin-Outs.
'Commercialisation of your regenerative medicine research; lessons from spin out successes' was hosted by Oxbridge Biotech Roundtable (OBR) (Oxford, UK) at the University of Oxford in February 2013, attracting a multi-stakeholder audience, spanning academia and industry. The event featured case studies from Gregg Sando, CEO, Cell Medica (London, UK), John Sinden, CSO, Reneuron (Guilford, UK) and Paul Kemp, CEO and CSO, Intercytex (Manchester, UK). OBR is a student led initiative with over 7,000 members acro...
Animal science. Rinderpest, deadly for cattle, joins smallpox as a vanquished disease.
Park M, Koh KN, Kim BE, Im HJ, Seo JJ. Clinical features of late onset non-infectious pulmonary complications following pediatric allogeneic hematopoietic stem cell transplantation. Clin Transplant 2010 DOI: 10.1111/j.1399-0012.2010.01357.x © 2010 John Wiley & Sons A/S. Abstract: Background: Late onset non-infectious pulmonary complications (LONIPCs) are major causes of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT). We evaluated the incidence and the...
Industry progress report on neuro-oncology: a biotech update.
With steadily rising revenue and large numbers of clinical trials utilizing novel treatment strategies, the field of neuro-oncology is at the core of the growing cancer therapy industry. In June 2012, the Weill Cornell Brain and Tumor Center hosted the first Brain Tumor Biotech Summit as a forum for fostering and encouraging collaboration between researches and investors to accelerate novel treatments for brain cancer. This event brought together neuro-oncologists, neurosurgeons, academicians, entrepreneurs...
BACKGROUND: BAFF (B-cell activating factor of the tumor necrosis factor family) and APRIL (a proliferation-inducing ligand) are two of the major survival factors for B cells. Many studies have shown that BAFF levels were elevated in MS patients. However, whether the levels of CSF BAFF/APRIL increased in NMO patients was still unclear. OBJECTIVE: To measure the CSF BAFF and APRIL concentration of in NMO patients, and explore their relationship with disease activity in NMO. METHODS: CSF BAFF and APRIL was mea...
Glutamate joins the ranks of immunomodulators.
Seasonal abundance and activity of all the three post-embryogenic stages of Haemaphysalis longicornis, both feeding and free-living phases, were evaluated over a period of 2 years, from February 2008 to January 2010, in North China. Feeding ticks were removed weekly from head and ears of domestic sheep and the attachment sites of this tick were assessed coinstantaneously; free-living ticks were collected weekly in four habitat types by flag-dragging. The results suggested that H. longicornis mainly resides...
Agbiotech. Can biotech and organic farmers get along?
NF-Y joins E2Fs, p53 and other stress transcription factors at the apoptosis table.
Activin A stimulates mouse macrophages to express APRIL via the Smad3 and ERK/CREB pathways.
A proliferation-inducing ligand (APRIL) is primarily expressed by macrophages and dendritic cells, and stimulates B cell proliferation, differentiation, survival, and Ig production. In the present study, we investigated the role and signaling mechanisms of activin A in APRIL expression by mouse macrophages. Activin A markedly enhanced APRIL expression in mouse macrophages at both the transcriptional and protein levels. Overexpression of dominant-negative (DN)-Smad3 and SB431542 abrogated activin-induced APR...
